In hospital laboratories, the colorful blood collection tubes are indispensable "health sentinels". These seemingly ordinary glass or plastic tubes, with their precise design and functional classification, undertake the critical tasks of blood sample collection, preservation, and testing, providing reliable evidence for clinical diagnosis.

The color-coding system of blood collection tubes serves as their core identifier, with each color corresponding to specific testing requirements. Purple-top tubes contain EDTA anticoagulant, specially designed for routine blood tests; blue-top tubes are added with sodium citrate, the exclusive choice for coagulation function testing; red or orange-red tubes are used for serological tests such as liver and kidney function assessment and infectious disease screening; green-top tubes are equipped with heparin, suitable for emergency biochemical analysis; gray-top tubes contain sodium fluoride to stabilize blood glucose and ensure testing accuracy. The standardized color system not only allows medical staff to quickly identify tubes but also avoids testing errors, representing an important part of medical standardization.

In terms of market structure, vacuum blood collection tubes dominate due to their high efficiency and safety, with an expected market share of 65% by 2030. Driven by population aging and the rising incidence of chronic diseases, the demand for blood collection tubes in clinical diagnosis continues to grow. In 2024, the demand for vacuum blood collection tubes in domestic medical institutions reached 7 billion pieces. Meanwhile, the development of precision medicine has promoted innovations in special blood collection tubes. Multi-chamber tubes with separation gel, which can separate serum and plasma components simultaneously, have become standard equipment in high-end medical institutions.

Technological innovation has driven continuous upgrades of blood collection tubes. From early glass tubes to today's plastic materials, and from manual collection to automated systems, blood collection tubes are moving toward intelligence. Smart tubes integrated with biosensors can automatically record collection time and precisely control additive dosage, significantly improving testing efficiency and reliability. Supported by policies and advances in medical technology, the market size of the blood collection tube industry is expected to reach 15 billion yuan by 2025, providing solid support for the Healthy China initiative.

These small colored tubes are not only basic tools for medical testing but also a microcosm of the development of medical technology, quietly guarding everyone's health.